Nasdaq · Healthcare
RMR GROUP INC. (RMR)
As-reported financials and recent SEC filings for RMR GROUP INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$700.3M
Net income
$17.6M
Net margin
2.5%
Diluted EPS
$1.03
ROE
4.4%
P/E (TTM)
17.3×
Market cap
$357.1M
Debt / equity
0.1×
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $700.3M | $897.6M | $962.3M | $832.5M | $607.2M |
| Gross profit | — | — | — | — | — |
| Operating income | $41.8M | $45.0M | $113.7M | $88.4M | $72.1M |
| Net income | $17.6M | $23.1M | $57.1M | $34.0M | $35.7M |
| Diluted EPS | $1.03 | $1.38 | $3.44 | $4.08 | $4.30 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
8-K2026-06-23
View on EDGAR →8-K2026-06-01
View on EDGAR →SCHEDULE 13G2026-05-14
View on EDGAR →8-K2026-05-07
View on EDGAR →10-Q2026-05-06
View on EDGAR →8-K2026-05-06
View on EDGAR →SCHEDULE 13G2026-04-29
View on EDGAR →SCHEDULE 13G2026-04-08
View on EDGAR →Go deeper on RMR
Search RMR GROUP INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.